IgA nephropathy: open trials in Spain

11 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT06963827
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Trial Treatment · Phase 3 · Takeda
Hospital Germans Trias i Pujol, Badalona · Hospital Universitario de Cruces, Barakaldo · Hospital Universitari Vall d'Hebron, Barcelona · Hospital del Mar, Barcelona · Hospital Universitario Fundación Jiménez Díaz, Madrid · Clinica Universidad de Navarra, Madrid · Clínica Universidad de navarra, Pamplona · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-11-04
2024-519638-22-00
A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials
Trial Treatment · Phase 3 · Novartis Pharma AG
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitari de Girona Doctor Josep Trueta, Girona · Hospital Universitario 12 de Octubre, Madrid · Hospital de Manises, Manises · Hospital Universitario Virgen De La Macarena, Sevilla
Registry updated 2026-10-30
NCT07773727
A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN
Trial Treatment · Phase 2 · argenx
Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida, Lleida · Hospital de Manises, Manises · University Clinical Hospital Virgen De La Arrixaca, Murcia
Registry updated 2026-10-27
NCT07146906
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Hospital Clinic de Barcelona, Barcelona · Clínica Universidad de navarra, Pamplona · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Dr. Peset Aleixandre, Valencia
Registry updated 2026-10-21
NCT06989359
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Trial Treatment · Phase 2 · ADARx Pharmaceuticals, Inc.
Barcelona · Madrid · Seville
Registry updated 2026-10-20
NCT07498335
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Barcelona · Cadiz · Madrid
Registry updated 2026-10-15
NCT06935357
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Trial Treatment · Phase 3 · Biogen
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario Fundación Alcorcón, Alcorcón · Hospital Universitari Vall d'Hebron, Barcelona · Hospital del Mar, Barcelona · Fundació Puigvert, Barcelona · Hospital San Pedro De Alcántara, Cáceres · Hospital Universitario de Getafe, Getafe · Hospital Universitari de Girona Doctor Josep Trueta, Girona · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-10-14
NCT04557462
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Hospital Clinic de Barcelona, Barcelona · Clínica Universidad de navarra, Pamplona · Hospital Universitario De Salamanca, Salamanca
Registry updated 2026-10-05
NCT06858319
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Girona
Registry updated 2026-08-17
NCT07024563
Study of Ravulizumab in Pediatric Participants With Primary IgAN
Trial Treatment · Phase 3 · Alexion Pharmaceuticals, Inc.
Hospital Universitario Torrecárdenas, Almería · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-07-30
NCT05003986
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Trial Treatment · Phase 2 · Travere Therapeutics, Inc.
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario La Paz, Madrid · Hospital Universitario 12 de Octubre, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-05-12

All IgA nephropathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error